SK Biopharmaceuticals commenced research and development of new drugs in 1993 as part of our search for the next-generation growth engine of SK Group. The exciting ascend of SK Biopharmaceuticals began with the acquisition of FDA approval for clinical test for a new candidate drug substance in 1996.
* Investigational New Drug (IND) application: Application for approval of clinical tests on candidate substance, of which safety...
SK Biopharmaceuticals commenced research and development of new drugs in 1993 as part of our search for the next-generation growth engine of SK Group. The exciting ascend of SK Biopharmaceuticals began with the acquisition of FDA approval for clinical test for a new candidate drug substance in 1996.
* Investigational New Drug (IND) application: Application for approval of clinical tests on candidate substance, of which safety and efficacy have been verified in the preliminary clinical test, by testing them on human subjects
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.